Boctot, Noemie .

HRN: 06-72-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2025
CEFUROXIME 1.5GM (VIAL)
11/06/2025
11/07/2025
IV
1.5gm
Q8 X 3 Doses
S/P Primary LTCS With IUD Insertion
Waiting Final Action 
11/06/2025
CEFUROXIME 500MG (TAB)
11/06/2025
11/12/2025
ORAL
500mg
BID
S/P Primary LTCS With IUD Insertion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: